519
Views
21
CrossRef citations to date
0
Altmetric
Original Research

Self-nanoemulsifying ramipril tablets: a novel delivery system for the enhancement of drug dissolution and stability

, , , &
Pages 5435-5448 | Published online: 18 Jul 2019

References

  • Shahba AA-W, Ahmed AR, Alanazi FK, Mohsin K, Abdel-Rahman SI. multi-layer self-nanoemulsifying pellets: an innovative drug delivery system for the poorly water-soluble drug cinnarizine. AAPS PharmSciTech. 2018. doi:10.1208/s12249-018-0990-7
  • Shahba AA, Ahmed AR, Mohsin K, Abdel-Rahman SI, Alanazi FK. Solidification of cinnarizine self-nanoemulsifying drug delivery systems by fluid bed coating: optimization of the process and formulation variables. Pharmazie. 2017;72(3):143–151. doi:10.1691/ph.2017.608929442049
  • Tang B, Cheng G, Gu JC, Xu CH. Development of solid self-emulsifying drug delivery systems: preparation techniques and dosage forms. Drug Discov Today. 2008;13(13–14):606–612. doi:10.1016/j.drudis.2008.04.00618598917
  • Ekambaram P, Abdul HSA. Formulation and evaluation of solid lipid nanoparticles of. J Young Pharm. 2011;3(3):216–220. doi:10.4103/0975-1483.8376521897661
  • Shafiq S, Shakeel F, Khar RK. Enhanced stability of ramipril in nanoemulsion containing cremophor-EL: a technical note. AAPS PharmSciTech. 2008;9(4):1097–1101. doi:10.1208/s12249-008-9151-818958628
  • Rao S, Tan A, Boyd BJ, Prestidge CA. Synergistic role of self-emulsifying lipids and nanostructured porous silica particles in optimizing the oral delivery of lovastatin. Nanomedicine (Lond). 2014;9(18):2745–2759. doi:10.2217/nnm.14.3724938439
  • Nguyen TH, Tan A, Santos L, et al. Silica-lipid hybrid (SLH) formulations enhance the oral bioavailability and efficacy of celecoxib: an in vivo evaluation. J Control Release. 2013;167(1):85–91. doi:10.1016/j.jconrel.2013.01.01223353808
  • Tan A, Eskandar NG, Rao S, Prestidge CA. First in man bioavailability and tolerability studies of a silica-lipid hybrid (Lipoceramic) formulation: a phase I study with ibuprofen. Drug Deliv Transl Res. 2014;4(3):212–221. doi:10.1007/s13346-013-0172-925786876
  • Neeraj BAK, Abhilash C, Rubia C, Rajn B. A review on immediate release drug delivery system. Irjpas. 2014;4(1):78–87.
  • Gumaste SG, Dalrymple DM, Serajuddin ATM. Development of solid SEDDS, V: compaction and drug release properties of tablets prepared by adsorbing lipid-based formulations onto neusilin® US2. Pharm Res. 2013;30(12):3186–3199. doi:10.1007/s11095-013-1106-4
  • Mohsin K, Pouton C. The influence of the ratio of lipid to surfactant and the presence of cosolvent on phase behaviour during aqueous dilution of lipid-based drug delivery systems. J Drug Deliv Sci Technol. 2012;22(6):531–540. doi:10.1016/S1773-2247(12)50092-4
  • Pouton CW. Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and ‘self-microemulsifying’ drug delivery systems. Eur J Pharm Sci. 2000;11(Suppl 2):S93–98.11033431
  • Shahba AA, Mohsin K, Alanazi FK. Novel self-nanoemulsifying drug delivery systems (SNEDDS) for oral delivery of cinnarizine: design, optimization, and in-vitro assessment. AAPS PharmSciTech. 2012;13(3):967–977. doi:10.1208/s12249-012-9821-422760454
  • Alhasani KF, Mohsin K, ShakEEL F, Alanazi F. Development and validation of stability-indicating ultra high-performance liquid chromatography for ramipril analysis in pharmaceutical dosage forms and its application in lipid-based formulations. Orient J Chem. 2018;34(1):64–74. doi:10.13005/ojc
  • Shahba AA-W, Mohsin K, Alanazi FK, Abdel-Rahman SI. Optimization of self-nanoemulsifying formulations for weakly basic lipophilic drugs: role of acidification and experimental design. Braz J Pharm Sci. 2016;52(4):653–667. doi:10.1590/s1984-82502016000400009
  • Kazi M, Al-Qarni H, Alanazi FK. Development of oral solid self-emulsifying lipid formulations of risperidone with improved in vitro dissolution and digestion. Eur J Pharm Biopharm. 2017. doi:10.1016/j.ejpb.2017.01.015
  • Shazly G, Mohsin K. Dissolution improvement of solid self-emulsifying drug delivery systems of fenofibrate using an inorganic high surface adsorption material. Acta Pharm. 2015;65(1):29–42. doi:10.1515/acph-2015-000325781702
  • United States Pharmacopeial Convention. Powder flow. In: USP35 NF30, U. S. Pharmacopeia National Formulary Rockville (MD): United States Pharmacopeial; 2011:801–804.
  • Beakawi Al-Hashemi HM, Baghabra Al-Amoudi OS. A review on the angle of repose of granular materials. Powder Technol. 2018;330:397–417. doi:10.1016/j.powtec.2018.02.003
  • Abdel-Rahman AA, Alanazi FK. Basis of Industrial Pharmacy. 1st ed. Riyadh: Al Kayali CHair for Pharmaceutical Industry, College of Pharmacy, King Saud University; 2008.
  • United States Pharmacopeial Convention. Uniformity of the dosage forms In: USP35 NF30, U. S. Pharmacopeia National Formulary Rockville (MD): United States Pharmacopeial; 2011:420–423.
  • United States Pharmacopeial Convention. Tablet friability. In: USP35 NF30, U. S. Pharmacopeia National Formulary Rockville (MD): United States Pharmacopeial; 2011:867–868.
  • United States Pharmacopeial Convention. Disintegration. In: USP35 NF30, U. S. Pharmacopeia National Formulary Rockville (MD): United States Pharmacopeial; 2011:293–295.
  • Aulton M. Aulton’s Pharmaceutics: The Design and Manufacture of Medicines. 3rd ed. Edinburgh; New York: Churchill Livingstone; 2007.
  • El Maghraby GM, Elzayat EM, Alanazi FK. Development of modified in situ gelling oral liquid sustained release formulation of dextromethorphan. Drug Dev Ind Pharm. 2012;38(8):971–978. doi:10.3109/03639045.2011.63481122092113
  • The GCC Guidelines for Stability Testing of Active Pharmaceutical Ingredients (Apis) and Finished Pharmaceutical Products (Fpps) [Internet]; 2011.
  • Shahba AA, Alanazi FK, Abdel-Rahman SI. Stabilization benefits of single and multi-layer self-nanoemulsifying pellets: A poorly-water soluble model drug with hydrolytic susceptibility. PLoS One. 2018;13(7):e0198469. doi:10.1371/journal.pone.019846930024877
  • ICH. ICH Steering Committee, ICH Harmonized Tripartite Guidlines, Q1C, Stability Testing for New Dosage Forms; 1996.
  • ICH. ICH Steering Committee, ICH Harmonized Tripartite Guidlines, Q1A(R2), Stability Testing of New Drug Subtances and Products; 2003.
  • Date AA, Desai N, Dixit R, Nagarsenker M. Self-nanoemulsifying drug delivery systems: formulation insights, applications and advances. Nanomedicine (Lond). 2010;5(10):1595–1616. doi:10.2217/nnm.10.12621143036
  • Lipinski C. Poor aqueous solubility-an industry wide problem in drug discovery. Am Pharm Rev. 2002;5(3):82–85.
  • Müllertz A, Ogbonna A, Ren S, Rades T. New perspectives on lipid and surfactant based drug delivery systems for oral delivery of poorly soluble drugs. J Pharm Pharmacol. 2010;62(11):1622–1636. doi:10.1111/j.2042-7158.2010.01107.x21039546
  • Pouton CW, Porter CJ. Formulation of lipid-based delivery systems for oral administration: materials, methods and strategies. Adv Drug Deliv Rev. 2008;60(6):625–637. doi:10.1016/j.addr.2007.10.01018068260
  • Dou YX, Zhou JT, Wang TT, et al. Self-nanoemulsifying drug delivery system of bruceine D: a new approach for anti-ulcerative colitis. Int J Nanomedicine. 2018;13:5887–5907. doi:10.2147/IJN.S17414630319255
  • Bandivadekar MM, Pancholi SS, Shelke N. Preparation and characterization of solid SMEDDS by adsorbent techniques to improve dissolution profile of poorly aqueous soluble drug ramipril. Int Res J Pharm. 2011;2(6):85–90.
  • Odovic JV, Markovic BD, Trbojevic-Stankovic J, Vladimirov SM, Karljikovic-Rajic KD. Evaluation of ACE inhibitors lipophilicity using in silico and chromatographically obtained hydrophobicity parameters/Procena lipofilnosti ace inhibitora primenom in silico i hromatografski dobijenih parametara hidrofobnosti. Hemijska Industrija. 2013;67(2):209–217. doi:10.2298/HEMIND120522078O
  • Porter C, Pouton C, Cuine J, Charman W. Enhancing intestinal drug solubilisation using lipid-based delivery systems. Adv Drug Deliv Rev. 2008;60(6):673–691. doi:10.1016/j.addr.2007.10.01418155801
  • Saifee M, Zarekar S, Rao VU, Zaheer Z, Soni R, Burande S. Formulation and in vitro evaluation of solid-self-emulsifying drug delivery system (SEDDS) of glibenclamide. Am J Adv Drug Delivery. 2013;1(3):323–340.
  • Silva HD, Cerqueira MA, Vicente AA. Influence of surfactant and processing conditions in the stability of oil-in-water nanoemulsions. J Food Eng. 2015;167:89–98. doi:10.1016/j.jfoodeng.2015.07.037
  • Tian Y, Chen L, Zhang W. Influence of ionic surfactants on the properties of nanoemulsions emulsified by nonionic surfactants span 80/tween 80. J Dispers Sci Technol. 2016;37(10):1511–1517. doi:10.1080/01932691.2015.1048806
  • Patel VI. To Improve the Solubility of Poorly Water Soluble Drugs Using Porous Material. Brooklyn (NY): Industrial pharmacy, faculty of the arnold & marie schwartz college of Pharmacy and health sciences, Long Island University; 2009.
  • Kinnari P, Makila E, Heikkila T, Salonen J, Hirvonen J, Santos HA. Comparison of mesoporous silicon and non-ordered mesoporous silica materials as drug carriers for itraconazole. Int J Pharm. 2011;414(1–2):148–156. doi:10.1016/j.ijpharm.2011.05.02121601623
  • Limnell T, Santos HA, Makila E, et al. Drug delivery formulations of ordered and nonordered mesoporous silica: comparison of three drug loading methods. J Pharm Sci. 2011;100(8):3294–3306. doi:10.1002/jps.2257721520084